About the Immune Hematology Program
As one of the only pediatric immune hematology program in the country, we treat immune-related blood cell abnormalities through comprehensive, multidisciplinary care.
One of the newest programs within the Hematology Center at Texas Children’s Hospital, the Immune Hematology Program specializes in the treatment of disorders caused by immune destruction of blood cells.
The Immune Hematology Program offers comprehensive, state-of-the-art care, thorough evaluation and diagnosis, and access to all standard treatments as well as novel therapies in clinical trials.
Some of the conditions we treat include:
- Autoimmune hemolytic anemia (AIHA)
- Immune thrombocytopenia (ITP) including chronic ITP
- Neonatal alloimmune thrombocytopenia (NAIT)
- Neonatal hemolytic anemia
- Thrombotic thrombocytopenic purpura (TTP)
What makes our program so unique is that our team focuses solely on pediatric immune hematology. Our hematologists are experts in immune hematology and aim to provide the highest level of care available. We regularly provide consultations for local pediatricians and work closely with patients and families to ensure understanding of the diagnosis and treatment options.
We have a comprehensive support staff to help with understanding and coping with symptoms.
Following the latest guidelines, we offer a full scope of care through the experts at Texas Children’s Hematology Center as well as throughout the 40 subspecialties at Texas Children’s Hospital. Working closely with rheumatology, immunology, genetics, Texas Children’s Newborn Center and pathology, we carefully monitor patients for development of other immune problems now as well as throughout their lives.
We are actively researching the causes and treatments of these disorders as well as collaborating with leading centers around the country to offer our patients the best treatments available. We are also researching various aspects of ITP diagnosis and therapy.
Upcoming projects include development of ITP and AIHA registries to understand the natural history of these disorders in children.